English
Investors
Shareholders
EQT logo
About
Teams
Sustainability
Investments
Media
Important notice
14 December 2020
07:00 CET
EQT IX, through Roar BidCo AB, announces a public offer of SEK 220 in cash per share to the shareholders of Recipharm AB (publ) and SEK 1,427,010 in cash per Convertible Bond
#EQT IX
#Recipharm
For more information, click here.
EQT logo
Latest news
13 December 2024
EQT completes public offering of common stock of Kodiak Gas Services
13 December 2024
EQT Completes Acquisition of PropertyGuru
13 December 2024
EQT Exeter acquires two UK warehouses in Milton Keynes and Dartford
11 December 2024
EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million
06 December 2024
EQT Life Sciences leads Series A funding round for maternal health company Nua Surgical